The ovarian renin-angiotensin system in reproductive physiology

Frontiers in Neuroendocrinology

Volumn 18, Issue 3, 1997, Pages 247-291

  Yoshimura, Yasunori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Angiotensin II receptor; Angiotensin converting enzyme; Ovary; Prorenin; Renin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; CANDESARTAN; CHORIONIC GONADOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; PROGESTERONE; PRORENIN; RENIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CORPUS LUTEUM; ECTOPIC PREGNANCY; HUMAN; NONHUMAN; OOCYTE MATURATION; OVARY DISEASE; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; OVULATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN ANGIOTENSIN DISORDER; REVIEW; SPECIES DIFFERENCE; STEROIDOGENESIS;

EID: 0030790322     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1997.0152     Document Type: Article

References (235)

1. Adashi E Y, Resnick C E, D'Ercole A J, Svobod M E, Van Wyk J J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 6:1985;400-420.
2. Aguilera G, Millan M A, Harwood J P. Angiotensin II receptors in the gonads. Am J Hypertens. 2:1989;395-402.
3. Anderson P W, D'Ablaing G, Penny R, Sherrod A, Do Y S. Secretion of prorenin by a virilizing ovarian tumor. Gynecol Oncol. 45:1992;58-61.
4. Anderson P W, Macaulay L, Do Y S, Sherrod A, D'Ablaing G, Koss M, Shinagawa T, Tran B, Montz F J, Hsueh W A. Extrarenal renin-secreting tumors: Insights into hypertension and ovarian renin production. Medicine. 68:1989;257-268.
5. Anderson P W, Malarkey W B, Salk J, Kletsky O A, Hsueh W A. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects. J Clin Endocrinol Metab. 69:1989;518-522.
6. Atlas S A, Christofalo P, Hesson T, Sealey J E, Fritz L C. Immunological evidence that inactive renin is prorenin. Biochem Biophys Res Commun. 132:1985;1038-1045.
7. Atlas S A, Hesson T E, Sealey J E, Dharmgrongartama B, Laragh J H, Ruddy M C, Aurell M. Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonreal origin. J Clin Invest. 73:1984;437-447.
8. Audinot V, Rasolonjanahary R, Bertrand P, Priam M, Kordon C, Enjalbert A. Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3′,5′-monophosphate production in lactotroph cells. Endocrinology. 129:1991;2231-2239.
9. Baukal A J, Balla T, Hunyady L, Hausdorff W, Guillemette G, Catt K J. Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-trisphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem. 263:1988;6087-6092.
10. Beers W H. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell. 6:1975;379-386.
11. Bergh P A, Navot D. Ovarian hyperstimulation syndrome: A review of pathophysiology. J Assist Reprod Genet. 9:1992;429-438.
12. ++. J Biol Chem. 263:1987;10620-10624.
13. Bicsak T A, Ling N, DePaolo L V. Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicle rupture in gonadotropin-treated immature female rats. Biol Reprod. 44:1991;599-603.
14. Birabeau M A, Capponi A M, Vallotton M B. Solubilized adrenal angiotensin II receptors: Studies on the site of action of sodium and calcium ions and on the role of disulfide bridges. Mol Cell Endocrinol. 37:1984;181-189.
15. Blankenstijn P J, Derkx F HM, Van Geelen J A, DeJong F H, Schalekamp M ADH. Increase in plasma prorenin during the menstrual cycle of a bilaterally nephrectomized woman. Br J Obstet Gynecol. 97:1990;1038-1042.
16. Blundell T, Sibanda B L, Pearl L. Three dimensional structure, specificity, and catalytic mechanism of renin. Nature. 304:1983;273-275.
17. Bottari S P, deGasparo M, Steckelings U M, Levens N R. Angiotensin II receptor subtypes: Characterization, signalling, mechanisms, and possible physiological implications. Front Neuroendocrinol. 14:1993;123-171.
18. 2. Biochem Biophys Res Commun. 183:1992;206-211.
19. Bouhnik J, Fehrentz J A, Galen F X, Seyer R, Evin G, Castro B, Menard J, Corvol P. Immunologic identification of both plasma and human renal inactive renin as prorenin. J Clin Endocrinol Metab. 60:1985;399-401.
20. Brentjens J R, Matsuo S, Andres G A, Caldwell P RB, Zamboni L. Gametes contain angiotensin converting enzyme (kininase II). Experientia. 42:1986;399-402.
21. Brock T A, Alexander R W, Ekstein L S, Atkinson W J, Gimbrone M A Jr. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension. 7:1985;I-105-I-109.
22. Brock T A, Rittenhouse S E, Powers C W, Ekstein L S, Gimbrone M A Jr, Alexander R W. Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem. 260:1985;14158-14162.
23. Brunswig-Spickenheier B, Mukhopadhyay A K. Inhibitory effects of a tumor-promoting phorbol ester on luteinizing hormone-stimulated renin and prorenin production by cultured bovine theca cells. Endocrinology. 127:1990;2157-2165.
24. Brunswig-Spickenheier B, Mukhopadhyay A K. Characterization of angiotensin-II receptor subtype on bovine theca cells and its regulation by luteinizing hormone. Endocrinology. 131:1992;1445-1452.
25. Brunswig-Spickenheiner B, Mukhopadhyay A K. Effects of tumor necrosis factor-α on luteinizing hormone-stimulated prorenin production by bovine ovarian thecal cellsin vitro. Endocrinology. 133:1993;2515-2522.
26. Bumpus F M, Catt K J, Shiu A T, deGasparo M, Goodfriend T, Husain A, Peach M J, Taylor D G Jr, Timmermans P BMWM. Nomenclature for angiotensin II receptors: A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension. 17:1991;720-721.
27. Bumpus F M, Pucell A G, Daud A I, Husain A. Angiotensin II: An intraovarian regulatory peptide. Am J Med Sci. 295:1988;406-408.
28. Campbell D J, Habener J F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 78:1986;31-39.
29. Canipari R, Strickland S. Plasminogen activator in the ovary. Production and gonadotropin regulation of the enzyme in granulosa and theca cells. J Biol Chem. 260:1985;5121-5125.
30. Carson R S, Findlay J K, Clark I J, Burger H G. Estradiol-17β, testosterone, and androstenedione in ovine follicular fluid during growth and atresia of ovarian follicles. Biol Reprod. 24:1981;105-113.
31. Carson R S, Zhang Z, Hutchinson L A, Herington A C, Findlay J K. Growth factors in ovarian function. J Reprod Fert. 85:1988;735-746.
32. Cassis L A, Lynch K R, Peach M J. Localization of angiotensinogen mRNA in rat aorta. Cir Res. 62:1988;1259-1262.
33. Cedard L, Mignot T M, Guichard A, Boyer P, Zorn J R. Immunoreactive renin variations during fertile and infertile hyperstimulated cycles within vitro. Hum Reprod. 4:1989;403-407.
34. Chiu A T, Herblin W F, McCall D E, Ardecky R J, Carini D J, Dunica J V, Pease L J, Wong P C, Wexler R R, Johnson A L, Timmermans P BMWM. Identification of angiotensin II receptor subtype. Biochem Biophys Res Commun. 165:1989;196-203.
35. Chun S-Y, Billig H, Tilly J L, Furuta I, Tsafriri A, Hsueh A JW. Gonadotropin supression of apoptosis in cultured preovulatory follicles: Mediatory role of endogenous insulin-like growth factor I. Endocrinology. 135:1994;1845-1853.
36. Clauser E, Gaillard I, Wei L, Corvol P. Regulation of angiotensinogen gene. Am J Hypertens. 2:1989;403-410.
37. Clemmons D R, Elgin R G, Han V KM, Casella S J, D'Ercole A J, Van Wyk J J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor I. J Clin Invest. 77:1986;1548-1556.
38. Cornwallis C M, Skinner S L, Nayudu P L, Lopata A, Thatcher R L, Yeung S P, Whitworth J A. Follicular fluid renin concentration and IVF outcome. Hum Reprod. 5:1990;413-417.
39. Culler M D, Tarlatzis B C, Lightman A, Fernandez L A, DeCherney A H, Negro-Vilar A F, Naftolin F. Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab. 62:1986;613-615.
40. Daud A I, Bumpus F M, Husain A. Evidence for selective expression of angiotensin II receptors on atretic follicles in the rat ovary: An autoradiographic study. Endocrinology. 122:1988;2727-2734.
41. Daud A I, Bumpus F M, Husain A. Angiotensin II: Does it have a direct obligate role in ovulation? Science. 245:1989;870-871.
42. Daud A I, Bumpus F M, Husain A. Characterization of angiotensin-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation. Endocrinology. 126:1990;2927-2935.
43. Davoren J B, Kasson B G, Li C H, Hsueh A JW. Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: Relation to IGF action. Endocrinology. 119:1986;2155-2162.
44. Derkx F HM, Alberda A T, DeJong F H, Zeilmaker F H, Makovitz J W, Schalekamp A DH. Source of plasma prorenin in early and late pregnancy: Observations in patient with primary ovarian failure. J Clin Endocrinol Metab. 65:1987;349-353.
45. De Vito E, Guardia D C, Cabrera R R. A renin-like enzyme in rat luteal tissue: Evidence of local synthesis and its regulation during pregnancy. J Endocrinol. 128:1990;43-49.
46. Do Y S, Sherrod A, Lobo R A, Paulsen R J, Shinagawa T, Chen S, Kjas S, Hseuh W A. Human ovarian theca cells are a source of renin. Proc Natl Acad Sci USA. 85:1988;1957-1961.
47. Do Y S, Shinagawa T, Tam H, Inagami T, Hseuh W A. Characterization of pure human renal renin. Evidence for a subunit structure. J Biol Chem. 262:1987;1037-1043.
48. Doolittle R F. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science. 222:1983;417-419.
49. Douglas J G. Angiotensin receptor subtypes of the kidney cortex. Am J Physiol. 253:1987;F1-F7.
50. Downs S M, Longo F J. Effects of indomethacin on preovulatory follicles in immature superovulated mice. Am J Anat. 164:1982;265-274.
51. Dzau V J. Vascular renin-angiotensin: A possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol. 6:1984;S377-S382.
52. Dzau V J, Brenner A, Emmett N L. Evidence for renin in rat brain: Differentiation from other renin-like enzymes. Am J Physiol. 242:1982;E292-E297.
53. Dzau V J, Burt D W, Pratt R E. Molecular biology of the renin-angiotensin system. Am J Physiol. 255:1988;F563-F573.
54. Dzau V J, Gonzalez D, Ellison K, Churchill S, Emmett N L. Characterization of purified rabbit uterine renin: Influence of pregnancy on uterine inactive renin. Endocrinology. 120:1987;358-364.
55. Ehlers M RW, Riordan J F. Angiotensin-converting enzyme: Biochemistry and molecular biology. Hypertension: Pathophysiology, Diagnosis and Management. 1990;Raven Press, New York. p. 1217-1231.
56. Ekker M, Tronik D, Rougeon F. Extra-renal transcription of the renin genes in multiple tissues of mice and rat. Proc Natl Acad Sci USA. 86:1989;5155-5158.
57. Elgin R G, Busby W H, Clemmons D R. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proc Natl Acad Sci USA. 84:1987;3254-3258.
58. Eskildsen P C. Localization of renin in rabbit uterus by help of microdissection. Acta Pathol Microbiol Scand. 80:1972;241-252.
59. Espey L L. A review of factors that could influence membrane potentials of ovarian follicular cells during mammalian ovulation. Acta Endocrinol. 2:1992;1-31.
60. Fernandez A L, Tarlatzis V, Rzaza P J, DeCherney A J, Naftolin F. Renin-like activity in ovarian follicular fluid. J Clin Endocrinol Metab. 44:1985;219-223.
61. Fernandez L A, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med. 105:1985;141-145.
62. Ferrareti A P, Gianaroli L, Diotallevi L, Festi C, Trounson A. Dopamine treatment for severe hyperstimulation syndrome. Hum Reprod. 7:1992;180-183.
63. Ferris T F, Weir E K. Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. J Clin Invest. 71:1982;809-815.
64. Flores J A, Veldhuis J D, Leong D A. Angiotensin II induces calcium release in a subpopulation of single ovarian (granulosa) cells. Mol Cell Endocrinol. 81:1991;1-10.
65. Franci C R, Anselmo-Franci J A, McCann S M. Opposite effects of central immunoneutralization of angiotensin II or atrial natriuretic peptide on luteinizing hormone release in ovariectomized rats. Neuroendocrinology. 51:1990;683-687.
66. Franken A AM, Derkx F HM, Schalekamp M ADH, Man in t'Veld A J, Hop W CL, van Rens E H, de Jong P TVM. Association of high plasma prorenin with diabetic retinopathy. J Hypertens. 6:1988;461-463.
67. Franks S. Polycystic ovary syndrome: A changing perspective. Clin Endocrinol. 31:1989;87-120.
68. Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme: Induction by steroids in rabbit alveolar macrophages in culture. Science. 197:1977;64-65.
69. Ganong W F. The brain renin-angiotensin system. Annu Rev Physiol. 46:1984;17-31.
70. Ganong W F. Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol. 14:1993;233-249.
71. Ganong W F. Reproduction and the renin-angiotensin system. Neurosci Biobehav Rev. 19:1995;241-250.
72. Glance D G, Elder M G, Myatt L. Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon. Am J Obstet Gynecol. 151:1985;387-391.
73. Glorioso N, Atlas S A, Laragh J H, Jewelewicz R, Sealey J E. Prorenin in high concentrations in human ovarian follicular fluid. Science. 233:1986;1422-1424.
74. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation: An update review. Obstet Gynecol Surv. 44:1989;430-440.
75. Goldzeiher J W. Polycystic ovarian disease. Fertil Steril. 35:1981;371-394.
76. Gospodarowicz D, Tharkal K K. Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci USA. 75:1967;847-851.
77. 2. J Clin Invest. 88:1991;921-933.
78. Griendling K K, Murphy T J, Alexander R W. Molecular biology of the renin-angiotensin system. Circulation. 87:1993;1816-1828.
79. Griendling K K, Rittenhouse S E, Brock T A, Ekstein L S, Gimbrone M A Jr, Alexander R W. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem. 261:1986;5901-5906.
80. Griendling K K, Tsuda T, Berk B C, Alexander R W. Angiotensin II stimulation of vascular smooth muscle. J Cardiovasc Pharmacol. 14:1989;S27-S33.
81. Grimes R W, Matton P, Ireland J J. A comparison of histological and non-histological indices of atresia and follicular function. Biol Reprod. 37:1987;82-88.
82. Hagemann A, Nielsen A H, Assey R J, Hyttel P, Boland M P, Roche J F, Poulsen K. Prorenin and active renin concentrations in ovarian follicular fluid increase after the LH peak in superovulated heifers. Clin Exp Pharmacol Physiol. 21:1994;463-469.
83. Hakuno N, Koji T, Yano T, Kobayashi N, Tsutsumi O, Taketani Y, Nakane P K. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology. 137:1996;1938-1948.
84. Haning R V, Strawn E Y, Nolten W E. Pathophysiology of the ovarian hyperstimulation syndrome. Obstet Gynecol. 66:1985;220-224.
85. Hasid A. Atriopeptins decrease resting and hormone elevated cytosolic Ca in cultured mesangial cells. Am J Physiol. 253:1987;F1077-F1082.
86. Heinrikson R L, Poorman R A. The biochemistry and molecular biology of recombinant human renin and prorenin. Laragh J H, Brenner B M. Hypertension: Pathophysiology, Diagnosis and Management. 1990;1179-1196 Raven Press, New York.
87. Howard R B, Pucell A G, Bumpus F M, Husain A. Rat ovarian renin: Characterization and changes during the estrous. Endocrinology. 38:1988;695-702.
88. Hseuh A JW, Billing H, Tsafriri A. Ovarian follicle atresia: A hormonally controlled apoptotic process. Endocr Rev. 15:1994;707-724.
89. Husain A, Bumpus F M, DeSilva P, Speth R C. Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci USA. 84:1987;2489-2493.
90. Husain A, Smeby R, Wiek D, Dzau V J, Bumpus F M. Biochemical and immunological properties of dog brain isorenin. Endocrinology. 114:1984;2210-2215.
91. Ikeda T, Nakayama D, Gomi T, Sakurai J, Yamazaki T, Yuhara M. Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases. Nephron. 52:1989;72-75.
92. Ireland J J, Roche J F. Development of nonovulatory antral follicles in heifers: Changes in steroids in follicular fluid and receptors for gonadotropins. Endocrinology. 112:1983;150-156.
93. Itskovitz J, Bruneval P, Soubrier F, Thaler I, Corvol P, Sealey J E. Localization of renin gene expression to monkey ovarian theca cells byin situ. J Clin Endocrinol Metab. 75:1992;1374-1380.
94. Itskovitz J, Rubattu S, Levron J, Sealey J E. High concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy. J Clin Endocrinol Metab. 75:1992;906-910.
95. Itskovitz J, Rubattu S, Rosenwaks Z, Liu H C, Sealey J E. Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome ofin vitro. J Clin Endocrinol Metab. 72:1991;165-171.
96. Itskovitz J, Sealey J E, Glorioso N, Rosenwaks Z. Plasma prorenin response to hCG in ovarian hyperstimulated women: Correlation with the number of ovarian follicles and steroid hormone concentrations. Proc Natl Acad Sci USA. 84:1987;7285-7289.
97. Iwai N, Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 298:1992;257-260.
98. Jaatinen F A, Matinlauri I, Anttila L, Koskinen P, Erkkola R, Irjala K. Serum total renin is elevated in women with polycystic ovarian syndrome. Fertil Steril. 63:1995;1000-1004.
99. Jacob W, Jentrush K D, Maursberger B, Oehme P. Demonstration of angiogenesis activity in the corpus luteum of cattle. Exp Pathol. 13:1977;231-236.
100. Jaiswal N, Diz D I, Chappel M C, Kyosla M C, Ferrario C M. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension. 19:1992;II-56-II-61.
101. Jaiswal N, Tallant E A, Diz D I, Khosla M C, Ferrario C M. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 17:1991;1115-1120.
102. Johnson A L, Bridgham J T, Witty J P, Tilly J L. Susceptibility of avian ovarian granulosa cells to apoptosis is dependent upon stage of follicle development and is related to endogenous levels ofbcI. Endocrinology. 137:1996;2059-2066.
103. Johnson R M, Garrison J C. Epidermal growth factor and angiotensin II stimulate formation of inositol 1,4,5- and inositol 1,3,4-trisphosphate in hepatocytes. J Biol Chem. 262:1987;17285-17293.
104. Kakar S S, Riel K K, Neill J D. Differential expression of angiotensin II receptor subtype mRNA (AT-1A and AT-1B) in the brain. Biochem Biophys Res Commun. 185:1992;688-692.
105. Kakar S S, Seller J C, Devor D C, Musgrove L C, Neill J D. Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulation. Biochem Biophys Res Commun. 183:1992;1090-1096.
106. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 268:1993;24543-24546.
107. Kim S-J, Shinjo M, Fukamizu H, Usuki S, Murakami K. Identification of renin and renin messenger RNA sequence in rat ovary and uterus. Biochem Biophys Res Commun. 142:1987;169-175.
108. Kim S-J, Shinjo M, Tada M, Usuki S, Fukamizu A, Miyazaki H, Murakami K. Ovarian renin gene expression is regulated by follicle stimulating hormone. Biochem Biophys Res Commun. 146:1987;989-995.
109. Kitai H, Yoshimura Y, Wright K H, Santulli R, Wallach E E. Microvasculature of preovulatory follicles: Comparison ofin situin vitro. Am J Obstet Gynecol. 152:1985;889-895.
110. Kitzman P H, Hutz R J. In vitro. Cell Tissue Res. 268:1992;191-196.
111. Krakoff L A, Eisenfeld A J. Hormonal control of plasma renin substrate (angiotensinogen). Cir Res. 41:1977;43-46.
112. Kramer R E, Gallant S, Brownie A C. Actions of angiotensin II on aldosterone biosynthesis in the rat adrenal cortex. J Biol Chem. 255:1980;3442-3427.
113. Krulewitz A H, Baur W E, Fanburg B L. Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am J Physiol. 247:1984;C163-C168.
114. Krulewitz A H, Fanburg B L. Stimulation of bovine endothelial cell angiotensin-I converting enzyme activity by cyclic AMP-related agents. J Cell Physiol. 129:1986;147-150.
115. Kuji N, Sueoka K, Miyazaki T, Tanaka M, Oda T, Kobayashi T, Yoshimura Y. Involvement of angiotensin II in the process of gonadotropin-induced ovulation in rabbits. Biol Reprod. 55:1996;984-991.
116. Kumar R S, Thekkumkara T J, Sen G C. The mRNAs encoding the two angiotensin-converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites. J Biol Chem. 266:1991;3854-3862.
117. Kuo T-D, Endo K, Dharmarajan A M, Miyazaki T, Atlas S J, Wallach E E. Direct effect of angiotensin II onin vitro. J Reprod Fert. 92:1991;469-474.
118. Langlois D, Bégeot M, Berthelon M-C, Jaillard C, Saez J M. Angiotensin II potentiates agonist-induced 3′,5′-cyclic adenosine monophosphate production by cultured bovine adrenal cells through protein kinase C and calmodulin pathways. Endocrinology. 131:1992;2189-2195.
119. Lasen M, Hommel E, Parving H H, Lund-Andersen H. Protective effect of captopril on the blood retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefes Arch Clin Exp Opthalmol. 228:1990;505-509.
120. Lassègue B, Alexander R W, Clark M, Griendling K K. Angiotensin II-induced phosphatidylcholine hydrolysis in cultured vascular smooth muscle cells: Regulation and localization. Biochem J. 276:1991;19-25.
121. LeMaire W J. Mechanism of mammalian ovulation. Steroids. 54:1989;455-469.
122. Li X-M, Juorio A V, Murphy B D. Angiotensin II interferes with steroidogenesis in porcine granulosa cells. Biol Reprod. 53:1995;791-799.
123. Lieberman J, Sastre A. Angiotensin-converting enzyme activity in postmortem human tissues. Lab Invest. 48:1983;711-717.
124. Lightman A, Deschepper C F, Mellon S H, Ganong W F, Naftolin F. In situ. Gynecol Endocrinol. 1:1987;227-233.
125. Lightman A, Tarlatzis B C, Rzasa P J, Culler M D, Caride V J, Negro-Vilar A F, Lennard D, DeCherney A H, Naftolin F. The ovarian renin-angiotensin system: Renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol. 156:1987;808-816.
126. Lindpainter K, Wilhelm M J, Jin M, Unger T, Lang R E, Schoelkens B A, Ganten D. Tissue renin-angiotensin systems: Focus on the heart. J Hypertens. 5:1987;S33-S38.
127. Matinlauri I, Anttila L, Jaatinen F A, Koskinen P, Aalto M, Irjala K, Nikkanen V. Total renin after gonadotropin stimulation in polycystic ovarian disease. Fertil Steril. 63:1995;307-313.
128. Matsuo S, Caldwell P RB, Brentjens J R, Andres G. In vivoin situ. J Clin Invest. 75:1985;1369-1380.
129. McClure N, Leya J, Radwanska E, Rawlins R, Haning R V. Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod. 7:1992;758-764.
130. McGiff J C, Crowshaw K, Terragno N A, Lonigro A J. Renal prostaglandins: Possible regulators of the renal actions of pressor hormone. Nature. 227:1970;1255-1257.
131. McNatty K P, Heath D A, Henderson K M, Lun S, Hurst P R, Ellis L M, Montgomery G W, Morrison L, Thurley D C. Some aspects of thecal and granulosa cell function during follicular development in the bovine ovary. J Reprod Fertil. 72:1984;39-53.
132. McNatty K P, Smith D M, Makris A, Osathanondh R, Ryan K J. The microenvironment of the human antral follicle: Interralationships among the steroid levels in antral fluid, the population of granulosa cells, and status of the oocytein vivoin vitro. J Clin Endocrinol Metab. 49:1979;851-860.
133. Meunier K, Mignot T-M, Maria B, Guichard A, Zorn J-R, Cedard L. Predictive value of the active renin assay for the diagnosis of ectopic pregnancy. Fertil Steril. 55:1991;432-435.
134. Mondshein J S, Schomberg D W. Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. Science. 211:1989;1179-1180.
135. Morris B J, Iwamoto H S, Reid I A. Localization of angiotensinogen in rat liver by immunocytochemistry. Endocrinology. 105:1979;790-796.
136. Morris R S, Paulson R J. The ovarian renin angiotensin system: Recent advances and their relationship to assisted reproductive technologies. Assis Reprod Rev. 3:1993;2-10.
137. Morris R S, Paulson R J, Lindheim S R, Legro R S, Lobo R A, Sauer M V. Angiotensin-converting enzyme inhibition reverses luteal phase steroid production in oocytes donors. Fertil Steril. 63:1995;854-858.
138. Morris R S, Wong I L, Do Y S, Hsueh W A, Lobo R A, Sauer M V, Paulson R J. The pathophysiology of ovarian hyperstimulation syndrome (OHSS). A proposal role of the ovarian derived prorenin to angiotensin cascade (ODPAC). Mukhopadhyay A K, Raizoda M K. Tissue Renin-Angiotensin Systems. 1995;391-398 Plenum Press, New York.
139. Morris R S, Wong I L, Hatch I E, Gentschein E, Paulson R J, Lobo R A. Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism. Fertil Steril. 64:1995;1099-1103.
140. Mukhopadhyay A K, Holstein K, Szkudlinski M, Brunswig-Spickenheier B, Leidenberger F A. The relationship between prorenin levels in follicular fluid and follicular atresia in bovine ovaries. Endocrinology. 129:1991;2367-2375.
141. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt R E, Dzau V J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 268:1993;24539-24542.
142. Murdoch W J. Disruption of cellular associates within granulosal compartment of preovulatory ovine follicles: Relationship to maturation of the oocyte and regulation by prostaglandin. Cell Tissue Res. 252:1988;459-462.
143. Murphy T J, Alexander R W, Griendling K K, Runge M S, Bernstein K E. Isolation of cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 351:1991;233-236.
144. Navot D, Bergh P A, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril. 58:1992;249-261.
145. Navot D, Margalioth E J, Laufer N, Birkenfeld A, Relou A, Rosler A, Schenker J G. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril. 48:1987;57-61.
146. Nielsen A H, Hagemann A, Svenstrup B, Nielsen J, Poulsen K. Angiotensin II receptor density in bovine ovarian follicles relates to tissue renin and follicular size. Clin Exp Pharmacol Physiol. 21:1994;463-469.
147. Okubo H, Nakayama K, Tanaka T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem. 261:1986;319-323.
148. Oliver J E, Aitman T J, Powell J F, Wilson C A, Clayton R N. Insulin-like growth factor I (IGF-I) gene expression in the rat ovary is confined to the granulosa cells of developing follicles. Endocrinology. 124:1989;2671-2679.
149. Ong A CM, Eisen V, Rennie D P, Homburg R, Lachelin G CL, Jacobs H S, Slater J DH. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): A possible role for ovarian renin. Clin Endocrinol. 34:1991;43-49.
150. Oparil S. Angiotensin I converting enzyme inhibitors and analogues of angiotensin II. Genest J, Kuchel O, Hamel P, Cantin M. Hypertension. Physiopathology and Treatment. 1983;250-270 McGraw-Hill, New York.
151. Palumbo A, Jones C, Lightman A, Carcangiu M L, DeCherney A H, Naftolin F. Immunohistochemical localization of renin and angiotensin II in human ovaries. Am J Obstet Gynecol. 160:1989;8-14.
152. Palumbo A, Pourmotabbed G, Carcangiu M L, Androde-Gordon P, Rosa L, DeCherney A, Naftolin F. Immunohistochemical localization of renin and angiotensin in the ovary: Comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril. 60:1993;280-284.
153. Pandy K N, Inagami T. Regulation of renin-angiotensins by gonadotropic hormones in cultured murine Leydig tumor cells: Release of angiotensin but not renin. J Biol Chem. 261:1986;3934-3938.
154. Paulson R J, Do Y S, Hsueh W A, Eggena P, Lobo R A. Ovarian renin productionin vitroin vivo: Fertil Steril. 51:1989;634-638.
155. Pellicer A, Lightman A, Ariza A, DeCherney A H, Naftolin F, Littlefield B A. Follicular development is impaired by inhibitors of serine proteases in the rat. Am J Obstet Gynecol. 158:1988;670-676.
156. Pellicer A, Palumbo A, DeCherney A H, Naftolin F. Blockade of ovulation by an angiotensin antagonist. Science. 240:1988;1660-1661.
157. Peluso J J, Pappalardo A. Progesterone and cell-cell adhesion interact to regulate rat granulosa cell apoptosis. Biochem Cell Biol. 72:1994;547-551.
158. Pepperell J R, Memeth G, Yamada Y, Naftolin F. The type 1 angiotensin-II receptor mediates intracellular calcium mobilization in rat luteal cells. Endocrinology. 133:1993;1678-1684.
159. Peterson C M, Morioka N, Zhu C, Ryan J W, LeMaire W J. Angiotensin-converting enzyme inhibitors have no effect on ovulation and ovarian steroidogenesis in the perfused rat ovary. Reprod Toxicol. 7:1993;131-135.
160. Peterson C M, Zhu C, Mukaida T, Butler T A, Woessner J F Jr, LeMaire W J. The angiotensin II antagonist, saralasin, inhibits ovulation in the perfused rat ovary. Am J Obstet Gynecol. 168:1993;242-245.
161. Pobiner B F, Hewlett E L, Garrison J C. Role of Ni in coupling angiotensin receptors to inhibition of adenyl cyclase in hepatocytes. J Biol Chem. 260:1985;16200-16209.
162. Polishuk W Z, Schenker J G. Ovarian overstimulation syndrome. Fertil Steril. 20:1969;443-452.
163. Preston S L, Gestone P T, Behrman H R. Adenosine reverses calcium-dependent inhibition of follicle stimulating hormone action and induction of maturation in cumulus-enclosed rat oocytes. Endocrinology. 120:1987;1346-1353.
164. Pucell A G, Bumpus F M, Husain A. Rat ovarian angiotensin II receptors. J Biol Chem. 262:1987;7076-7080.
165. Pucell A G, Bumpus F M, Husain A. Regulation of angiotensin II receptors in cultured rat ovarian granulosa cells by follicle-stimulating hormone and angiotensin II. J Biol Chem. 263:1988;11954-11961.
166. Pucell A G, Hodges J C, Sen I, Bumpus F M, Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology. 128:1991;1947-1959.
167. Rainey W E, Bird J M, Byrd W, Carr B R. Effect of angiotensin II on human luteinized granulosa cells. Fertil Steril. 59:1993;143-147.
168. Rebar R, Judd H L, Yen S CC, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 57:1976;1320-1329.
169. Regoli D, Park W K. Pharmacology of angiotensin. Pharmacol Rev. 26:1974;69-123.
170. Reich R, Miskin R, Tsafriri A. Follicular plasminogen activator: involvement in ovulation. Endocrinology. 116:1985;516-521.
171. Rubattu S, Quimby F W, Sealey J E. Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens. 9:1991;525-535.
172. Ruegg U T, Burgress G M. Staurosporine, K-252, and UCN-01: Potent but not specific inhibitors of protein kinases. Trends Pharmacol Sci. 10:1989;218-220.
173. Ruilope L M, Miranda B, Oliet A, Millet V G, Rodicio J L, Romer J C, Raji L. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria. J Hypertens. 6:1988;467-469.
174. Sakuta H, Sekiguchi M, Okamoto K, Sakai Y. Endogenous angiotensin II receptors inXenopus. Eur J Pharmacol Mol Pharmacol. 208:1991;31-39.
175. 2. Biol Reprod. 33:1985;229-234.
176. Sandberg K, Bor M, Ji H, Markwick A, Millan M A, Catt K J. Angiotensin II-induced calcium mobilization in oocytes by signal transfer through gap junctions. Science. 249:1990;298-301.
177. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray J J, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 351:1991;230-232.
178. Sasamura H, Hein L, Krieger J E, Prat R E, Kobilka B K, Dzau V J. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun. 185:1992;253-259.
179. Sato E, Ishibashi T, Koide S S. Inducement of blood vessel formation by ovarian extracts from mice injected with gonadotropins. Experientia. 38:1982;1248-1249.
180. Schultze D, Brunswig R, Mukhopadhyay A K. Renin and prorenin-like activities in bovine ovarian follicles. Endocrinology. 124:1989;1389-1398.
181. Sealey J E, Atlas S A, Glorioso N, Manapat H, Laragh J H. Cyclical secretion of prorenin during the menstrual cycle: Synchronization with luteinization hormone and progesterone. Proc Natl Acad Sci USA. 82:1985;8705-8709.
182. Sealey J E, Cholst I, Glorioso N, Troffa C, Weintraub I D, James G, Laragh J H. Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab. 63:1987;1-5.
183. Sealey J E, Glorioso N, Itskovitz J, Jaragh J H. Prorenin as a reproductive hormone: A new form of the renin system. Am J Med. 81:1986;1041-1046.
184. Sealey J E, Glorioso N, Itskovitz J, Troffa C, Cholst I, Rosenwaks Z. Plasma prorenin during early pregnancy: Ovarian secretion under gonadotropin control? J Hypertens. 4:1986;S92-S95.
185. Sealey J E, Rubattu S. Prorenin and renin as separate mediators of tissues and circulating systems. Am J Hypertens. 2:1989;358-366.
186. Sealey J E, White R P, Laragh J H. Plasma prorenin and renin in anephric patients. Circ Res. 41:1977;17-21.
187. Sechi L, Griffin C A, Grady E F, Kalinyak J E, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 71:1992;1482-1489.
188. Seibel M M, Smith D, Dlugi A M, Levesque L. Periovulatory follicular fluid hormone levels in spontaneous human cycles. J Clin Endocrinol Metab. 68:1989;1073-1077.
189. Seibel M M, Swartz S L, Smith D, Levesque L, Taymor M L. In vivo. Fertil Steril. 42:1984;482-485.
190. Shinagawa T, Do Y S, Baxter J, Hseuh W A. Purification and characterization of human truncated prorenin. Biochemistry. 31:1992;2758-2764.
191. Skeggs L T, Kahn J R, Shumway N P. Preparation and function of the hypertension-converting enzyme. J Exp Med. 103:1956;295-299.
192. Smith J B, Lincoln T M. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol. 253:1987;C147-C150.
193. Speth R C, Husain A. Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod. 38:1988;695-702.
194. Squires P M, Kennedy T G. Evidence for a role for a uterine renin-angiotensin system in decidualization in rats. J Reprod Fert. 95:1992;791-802.
195. Steele M K. The role of brain angiotensin II in the regulation of luteinizing hormone and prolactin secretion. Trends Endo Metab. 3:1992;295-301.
196. Steele M K, Ganong W F. Branin renin-angiotensin system and secretion of luteinizing hormone and prolactin. Front Neuroendocrinol. 9:1986;99-113.
197. Stirling D, Magness R R, Stone R, Waterman M R, Simpson E R. Angiotensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem. 265:1990;5-8.
198. Stornello M, Valvo E V, Puglia N, Scapellato L. Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria. J Hypertens. 6:1988;464-466.
199. Sumners C, Tang W, Zelezna B, Raizada M K. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA. 88:1991;7567-7571.
200. 2. Biochem Biophys Res Commun. 198:1994;60-66.
201. Tanaka M, Ohnishi J, Ozawa Y, Sugimoto M, Usuki S, Naruse M, Murakami K, Miyazaki H. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem Biophys Res Commun. 207:1995;593-598.
202. Thekkumkara T J, Livingston W III, Kumar R S, Sen G C. Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs. Nucleic Acids Res. 20:1992;683-687.
203. Thibault C, Levasseur M C. Ovulation. Hum Reprod. 3:1988;513-523.
204. Thomas W G, Sernia C. The immunocytochemical localization of angiotensinogen in the rat ovary. Cell Tissue Res. 261:1990;367-373.
205. Tilly J L, Kowalski K I, Johnson A L, Hsueh A W. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology. 129:1991;2799-2801.
206. Tilly J L, Tilly K I. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology. 136:1995;242-252.
207. Tornell J, Carlsson B, Billing H. Atrial natriuretic peptide inhibits spontaneous rat oocyte maturation. Endocrinology. 126:1990;1504-1508.
208. Tronik D, Ekker M, Rougeon F. Structural analysis of the 5′-flanking regions of rat, mouse, and human renin genes reveals the presence of a transposable-like element in the mouse genes. Gene. 69:1988;71-80.
209. Tsafriri A, Bicsak T A, Cajander S G, Ny T, Hsueh A JW. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and α2-antiplasmin. Endocrinology. 124:1989;415-421.
210. Tsang S S, Loscalzo J, Dzau V J. Tissue plasminogen activator activates renin angiotensinin vitro. J Vasc Med Biol. 1:1989;67-74.
211. 12. Am J Physiol. 261:1991;R209-R216.
212. Tsutsumi K, Viswanathan M, Stromberg C, Saavedra J M. Type-1 and Type-2 angiotensin II receptors in feral rat brain. Eur J Pharmacol. 198:1991;89-92.
213. van Sande M E, Scharpé S L, Neels H M, Van Camp K O. Distribution of angiotensin converting enzyme in human tissues. Clin Chim Acta. 147:1985;255-260.
214. Velletri P A. Testicular angiotensin I-converting enzyme (EC 3.4.15.1). Life Sci. 36:1985;1597-1608.
215. Wang J, Baimbridge K G, Leung P CK. Perturbation of intracellular calcium ion concentration in single rat granulosa cells by angiotensin II. Endocrinology. 124:1989;1094-1096.
216. Webb M L, Liu E C-K, Cohen R B, Hedberg A, Bogosian E A, Monshizadegan H, Molloy C, Serafino R, Moreland S, Murphy T J, Dickinson K EJ. Molecular characterization of angiotensin II type 2 receptors in rat pheochromocytoma cells. Peptides. 13:1992;499-508.
217. Weinberger M H, Wade M B, Aoi W, Usa T, Dentino M, Luft F, Grim C E. An extrarenal source of "renin-like" activity in anephric man. Circ Res. 40:1977;1-5.
218. Whitebread S, Mele M, Kamber B, deGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 163:1989;284-291.
219. Wilson C M, Erdos E G, Dunn S F, Wilson W D. Genetic control of renin activity in the submaxillary gland of the mouse. Proc Natl Acad Sci USA. 74:1977;1185-1189.
220. Yamada T, Horiuchi M, Dzau V J. Angiotensin II type 2 receptor mediates programmed cell dealth. Proc Natl Acad Sci USA. 93:1996;156-160.
221. Yoshimura Y, Ando M, Nagamatsu S, Iwashita M, Adachi T, Sueoka K, Miyazaki T, Kuji N, Tanaka M. Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biol Reprod. 55:1996;152-160.
222. Yoshimura Y, Aoki N, Sueoka K, Miyazaki T, Kuji N, Tanaka M, Kobayashi T. Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation. J Clin Invest. 98:1996;308-316.
223. Yoshimura Y, Dharmarajan A M, Gips S, Adachi T, Hosoi Y, Atlas S J, Wallach E E. Effects of prostacyclin on ovulation and microvasculature of thein vitro. Am J Obstet Gynecol. 159:1988;977-982.
224. Yoshimura Y, Espey L, Hosoi Y, Adachi T, Atlas S J, Ghodgaonkar R B, Dubin N H, Wallach E E. The effects of bradykinin on ovulation and prostaglandin production by the perfused rabbit ovary. Endocrinology. 122:1988;2540-2546.
225. Yoshimura Y, Iwashita M, Karube M, Oda T, Akiba M, Shiokawa S, Ando M, Yoshinaga A, Nakamura Y. Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I. Endocrinology. 135:1994;887-894.
226. Yoshimura Y, Jinno M, Oda T, Shiokawa S, Yoshinaga A, Hanyu I, Akiba M, Nakamura Y. Prolactin inhibits ovulation by reducing ovarian plasmin generation. Biol Reprod. 50:1994;1223-1230.
227. 2. Endocrinology. 137:1996;1204-1211.
228. Yoshimura Y, Karube M, Koyama N, Shiokawa S, Nanno T, Nakamura Y. Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit. FEBS Lett. 307:1992;305-308.
229. Yoshimura Y, Karube M, Oda T, Koyama N, Shiokawa S, Akiba M, Yoshinaga A, Nakamura Y. Locally produced angiotensin II induces ovulation by stimulating prostaglandin production in in vitro perfused rabbit ovaries. Endocrinology. 133:1993;1609-1616.
230. Yoshimura Y, Koyama N, Karube M, Oda T, Akiba M, Yoshinaga A, Shiokawa S, Jinno M, Nakamura Y. Gonadotropin stimulates ovarian renin-angiotensin system in the rabbit. J Clin Invest. 93:1994;180-187.
231. Yoshimura Y, Maruyama K, Shiraki M, Kawakami S, Fukushima M, Nakamura Y. Prolactin inhibits plasminogen activator activity in the preovulatory follicles. Endocrinology. 126:1990;631-636.
232. Yoshimura Y, Nagamatsu S, Ando M, Iwashita M, Oda T, Katsumata Y, Shiokawa S, Nakamura Y. Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary. Endocrinology. 137:1996;438-446.
233. Yoshimura Y, Nakamura Y, Oda T, Ando M, Ubukata Y, Koyama N, Karube M, Yamada H. Effects of prolactin on ovarian plasmin generation in the process of ovulation. Biol Reprod. 46:1992;322-327.
234. Yoshimura Y, Santulli R, Atlas S J, Fujii S, Wallach E E. The effects of proteolytic enzymes onin vitro. Am J Obstet Gynecol. 157:1987;468-475.
235. Yoshimura Y, Wallach E E. Studies of the mechanism(s) of mammalian ovulation. Fertil Steril. 47:1987;22-34.